Anti-nerve growth factor antibodies for the treatment of low back pain |
| |
Authors: | Falin Patel Demere K. Hess |
| |
Affiliation: | Department of Anesthesiology and Critical Care, Johns Hopkins School of Medicine , Baltimore, MD, USA |
| |
Abstract: | ABSTRACT Introduction The treatment of chronic low back pain (cLBP) often involves multimodal pharmacologic and non-pharmacologic strategies. There remain shortcomings with these tools with regards to both effect size and side effects. |
| |
Keywords: | Chronic pain low back pain monoclonal antibodies nerve growth factors tanezumab fasinumab |
|